Engineering
immunity
for life.
Tendel was founded to discover, develop, and deliver first-in-class memory promoting vaccines.
[Our Technology]
An adjuvant toolkit for genetic vaccines.
We believe broadly neutralizing antibodies and non-traditional T-cell responses will redefine vaccinology.
Our proprietary adjuvants are delivered by any vectored platform and drive differentiated immunity of exceptional breadth, power, and durability.
[Our Mission]
Fighting humanity’s toughest infections and battling cancer.
People
Leadership
Corey Miller, MD, PhD
CEO
Dennis Hartigan-O’Connor, MD, PhD
Co-Founder
Sean Hartigan
General Counsel
Scientific Advisors
Peter Barry, PhD
University of California, Davis
Christian Brander, PhD
IrsiCaixa Aids Research Institute
Steven Deeks, MD
University of California, San Francisco